Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.8941
-0.0360 (-3.87%)
At close: Apr 29, 2026, 4:00 PM EDT
0.9043
+0.0102 (1.14%)
Pre-market: Apr 30, 2026, 7:08 AM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $31.41 million as of April 30, 2026. Its market cap has decreased by -22.64% in one year.
Market Cap
31.41M
Enterprise Value
5.94M
1-Year Change
-22.64%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $31.41M, a decrease of -91.18%. That is a compound annual growth rate of -69.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 29.80M | 24.17% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aligos Therapeutics | 39.73M |
| Atara Biotherapeutics | 39.42M |
| Veru Inc. | 38.84M |
| INmune Bio | 38.28M |
| NextCure | 37.78M |
| CervoMed | 36.62M |
| Palatin Technologies | 35.53M |
| Evaxion | 35.53M |